North America Sarcopenia Treatment Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	138 Pages	Data Bridge Market Research	October, 2023	DAABD18360567

Best Price Guarantee
Price	from $3,500
Length	138 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2023
SKU	DAABD18360567

North America Sarcopenia Treatment Market - Industry Trends and Forecast to 2030

The North America sarcopenia treatment market is expected to reach USD 1,814,892.90 thousand by 2030 from USD 1,235,920.05 thousand in 2022, growing at a CAGR of 5.0% during the forecast period of 2023 to 2030.

Market Segmentation
North America Sarcopenia Treatment Market, By Treatment Type (Medications, Vitamin/Dietary Supplements, and Others), Type (Primary Sarcopenia and Secondary Sarcopenia), Stages (Pre-Sarcopenia, Sarcopenia, and Severe Sarcopenia), Route of Administration (Oral, Injectable, And Others), Gender (Male and Female), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) Country ( U.S., Canada, and Mexico) – Industry Trends and Forecast to 2030
Overview of North America Sarcopenia Treatment Market Dynamics

Drivers
• Rising prevalence of sarcopenia
• Growing awareness of sarcopenia and its detrimental effects on health
Restraint

• Lack of standardized diagnosis
Opportunity

• Strategic initiatives by market players
Market Players
Some of the major market players operating in the North America sarcopenia treatment market are:
• Abbott.
• Nestlé Health Science ( A subsidary of Nestlé S.A.)
• Novartis AG
• Sanofi
• Haleon Group of Companies.
• BASF SE
• Bio Thrive Sciences
• DSM
• Fermenta Biotech Limited
• AstaReal Co., Ltd.
• Metagenics
• Wellona Pharma
• The Vitamin Company India
• Healing Pharma India Pvt. Ltd.
• OPKO Health, Inc.
• MyMD Pharmaceuticals
• Regeneron Pharmaceuticals Inc.
• Biophytis
• ARMGO Pharma, Inc.
• Dystrogen Therapeutics Corp.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Sarcopenia Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Treatment Type Segment Lifeline Curve; 2.8 Market End User Coverage Grid; 2.9 Dbmr Market Position Grid; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces
5 North America Sarcopenia Treatment Market: Regulations: 5.1 Regulations In The U.S.; 5.2 Regulations In Canada; 5.3 Regulations In Mexico
6 Market Overview: 6.1 Drivers; 6.1.1 Rising Prevalence Of Sarcopenia; 6.1.2 Growing Awareness Of Sarcopenia And Its Detrimental Effects On Health; 6.1.3 Lifestyle Factors Such As Poor Nutrition And Sedentary Behaviour 6.2 Restraints; 6.2.1 Lack Of Standardized Diagnosis; 6.2.2 High Cost Of Treatment And Interventions; 6.3 Opportunities; 6.3.1 Strategic Initiatives By Market Players; 6.3.2 Increasing Research And Development Activities; 6.4 Challenges; 6.4.1 Complications Associated With The Sarcopenia Treatment; 6.4.2 Stringent Government Rules And Regulation For Product Approval
7 North America Sarcopenia Treatment Market, By Treatment Type: 7.1 Overview; 7.2 Vitamin/Dietary Supplements; 7.2.1 Vitamin Supplements; 7.2.2 Protein Supplements; 7.2.3 Fatty Acid Supplements; 7.2.4 Creatine; 7.2.5 Whey Proteins; 7.2.6 L-carnitine; 7.2.7 Soy; 7.2.8 Beta-alanine; 7.2.9 Ostarine; 7.2.10 Collagen Peptides; 7.2.11 Ligandrol; 7.2.12 Branch-chain Amino Acids; 7.2.13 Hydroxymethylbutyrate (Hmb); 7.2.14 Medium Chain Triglycerides; 7.2.15 Others; 7.3 Medications; 7.3.1 Off Label Drugs; 7.3.2 Emerging Drugs; 7.3.2.1 Ace Inhibitors; 7.3.2.2 Appetite Stimulants; 7.3.2.3 Oral Antidiabetic Drugs; 7.3.2.4 Others; 7.4 Others 8 North America Sarcopenia Treatment Market, By Type; 8.1 Overview; 8.2 Primary Sarcopenia; 8.2.1 Vitamin/Dietary Supplements; 8.2.2 Medications; 8.2.3 Others; 8.3 Secondary Sarcopenia; 8.3.1 Vitamin/Dietary Supplements; 8.3.2 Medications; 8.3.3 Others
9 North America Sarcopenia Treatment Market, By Stages: 9.1 Overview; 9.2 Pre-sarcopenia; 9.3 Sarcopenia; 9.4 Severe Sarcopenia
10 North America Sarcopenia Treatment Market, By Route Of Administration: 10.1 Overview; 10.2 Oral; 10.3 Injectables; 10.4 Others
11 North America Sarcopenia Treatment Market, By Gender: 11.1 Overview; 11.2 Male; 11.3 Female
12 North America Sarcopenia Treatment Market, By End User: 12.1 Overview; 12.2 Hospitals; 12.2.1 Public; 12.2.2 Private; 12.3 Specialty Clinics; 12.4 Home Healthcare; 12.5 Others 13 North America Sarcopenia Treatment Market, By Distribution Channel; 13.1 Overview; 13.2 Direct Tender; 13.3 Retail Sales; 13.3.1 Hospital Pharmacies; 13.3.2 Online Pharmacies; 13.3.3 Others; 13.4 Others
14 North America Sarcopenia Treatment Market By Country: 14.1 North America; 14.1.1 U.S.; 14.1.2 Canada; 14.1.3 Mexico
15 North America Sarcopenia Treatment Market, Company Landscape: 15.1 Company Share Analysis: North America
16 Swot Analysis
17 Company Profile: 17.1 Abbott; 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Product Portfolio; 17.1.4 Recent Development; 17.2 Nestlé Health Science (A Subsidiary Of Nestlé S.A.); 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Product Portfolio; 17.2.4 Recent Development; 17.3 Novartis Ag; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Product Portfolio; 17.3.4 Pipeline Portfolio; 17.3.5 Recent Development 17.4 Sanofi; 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.5 Product Portfolio; 17.5.1 Recent Development; 17.6 Haleon Group Of Companies.; 17.6.1 Company Snapshot; 17.6.2 Revenue Analysis; 17.6.3 Product Portfolio; 17.6.4 Recent Development; 17.7 Astareal Co., Ltd.; 17.7.1 Company Snapshot; 17.7.2 Product Portfolio; 17.7.3 Recent Development; 17.8 Basf Se; 17.8.1 Company Snapshot; 17.8.2 Revenue Analysis; 17.8.3 Product Portfolio; 17.8.4 Recent Development; 17.9 Biothrive Sciences; 17.9.1 Company Snapshot; 17.9.2 Product Portfolio; 17.9.3 Recent Development; 17.10 Dsm; 17.10.1 Company Snapshot; 17.10.2 Revenue Analysis; 17.10.3 Product Portfolio; 17.10.4 Recent Development; 17.11 Fermenta Biotech Limited; 17.11.1 Company Snapshot; 17.11.2 Revenue Analysis; 17.11.3 Product Portfolio; 17.11.4 Recent Development; 17.12 Healing Pharma India Pvt.Ind.; 17.12.1 Company Snapshot; 17.12.2 Product Portfolio; 17.12.3 Recent Development 17.13 Metagenics; 17.13.1 Company Snapshot; 17.13.2 Product Portfolio; 17.13.3 Recent Development; 17.14 The Vitamin Company India; 17.14.1 Company Snapshot; 17.14.2 Product Portfolio; 17.14.3 Recent Development; 17.15 Wellona Pharma; 17.15.1 Company Snapshot; 17.15.2 Product Portfolio; 17.15.3 Recent Development; 17.16 Armgo Pharma, Inc.; 17.16.1 Company Snapshot; 17.16.2 Pipeline Portfolio; 17.16.3 Recent Development; 17.17 Biophytis; 17.17.1 Company Snapshot; 17.17.2 Pipeline Portfolio; 17.17.3 Recent Development; 17.18 Dystrogen Therapeutics Corp; 17.18.1 Company Snapshot; 17.18.2 Pipeline Portfolio; 17.18.3 Recent Development; 17.19 Mymd Pharmaceuticals; 17.19.1 Company Snapshot; 17.19.2 Pipeline Portfolio; 17.19.3 Recent Development; 17.20 Opko Health, Inc.; 17.20.1 Company Snapshot; 17.20.2 Revenue Analysis; 17.20.3 Pipeline Portfolio; 17.20.4 Recent Development; 17.21 Regeneron Pharmaceuticals Inc.; 17.21.1 Company Snapshot; 17.21.2 Revenue Analysis; 17.21.3 Pipeline Portfolio; 17.21.4 Recent Development 134
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 North America Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 2 North America Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 3 North America Medicatinons In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 4 North America Off-lable Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 5 North America Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 6 North America Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 7 North America Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 8 North America Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 9 North America Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 10 North America Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 11 North America Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 12 North America Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 13 North America Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 14 North America Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 15 North America Sarcopenia Treatment Market, By Country, 2021-2030 (Usd Thousand); Table 16 U.S. Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 17 U.S. Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 18 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 19 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume); Table 20 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp); Table 21 U.S. Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 22 U.S. Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 23 U.S. Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 24 U.S. Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 25 U.S. Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 26 U.S. Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 27 U.S. Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 28 U.S. Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 29 U.S. Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 30 U.S. Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 31 U.S. Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 32 Canada Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 33 Canada Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 34 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 35 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume); Table 36 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp); Table 37 Canada Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 38 Canada Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 39 Canada Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 40 Canada Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 41 Canada Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 42 Canada Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 43 Canada Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 44 Canada Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 45 Canada Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 46 Canada Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 47 Canada Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 48 Mexico Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 49 Mexico Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 50 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 51 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume); Table 52 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp); Table 53 Mexico Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 54 Mexico Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 55 Mexico Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 56 Mexico Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 57 Mexico Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 58 Mexico Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 59 Mexico Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 60 Mexico Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 61 Mexico Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 62 Mexico Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 63 Mexico Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
List Of Figures: Figure 1 North America Sarcopenia Treatment Market: Segmentation; Figure 2 North America Sarcopenia Treatment Market: Data Triangulation; Figure 3 North America Sarcopenia Treatment Market: Droc Analysis; Figure 4 North America Sarcopenia Treatment Market: Regional Market Analysis; Figure 5 North America Sarcopenia Treatment Market: Company Research Analysis; Figure 6 North America Sarcopenia Treatment Market: Interview Demographics; Figure 7 North America Sarcopenia Treatment Market: Market End Users Coverage Grid; Figure 8 North America Sarcopenia Treatment Market: Dbmr Market Position Grid; Figure 9 North America Sarcopenia Treatment Market: Segmentation; Figure 10 The Rising Prevalence Of Sarcopenia And Growing Awareness Of Sarcoepnia And Its Detrimental Effect On Health Are Expected To Drive The Growth Of The North America Sarcopenia Treatment Market From 2023 To 2030; Figure 11 Vitamin/Dietary Supplements Segment Is Expected To Account For The Largest Share Of The North America Sarcopenia Treatment Market In 2023 And 2030; Figure 12 Drivers, Restraints, Opportunities, And Challenges Of The North America Sarcopenia Treatment Market; Figure 13 North America Sarcopenia Treatment Market: By Treatment Type, 2022; Figure 14 North America Sarcopenia Treatment Market: By Treatment Type, 2023-2030 (Usd Thousand); Figure 15 North America Sarcopenia Treatment Market: By Treatment Type, Cagr (2023-2030); Figure 16 North America Sarcopenia Treatment Market: By Treatment, Lifeline Curve; Figure 17 North America Sarcopenia Treatment Market: By Type, 2022; Figure 18 North America Sarcopenia Treatment Market: By Type, 2023-2030 (Usd Thousand); Figure 19 North America Sarcopenia Treatment Market: By Type, Cagr (2023-2030); Figure 20 North America Sarcopenia Treatment Market: By Type, Lifeline Curve; Figure 21 North America Sarcopenia Treatment Market: By Stages, 2022; Figure 22 North America Sarcopenia Treatment Market: By Stages, 2023-2030 (Usd Thousand); Figure 23 North America Sarcopenia Treatment Market: By Stages, Cagr (2023-2030); Figure 24 North America Sarcopenia Treatment Market: By Stages, Lifeline Curve; Figure 25 North America Sarcopenia Treatment Market: By Route Of Administration, 2022; Figure 26 North America Sarcopenia Treatment Market: By Route Of Administration, 2023-2030 (Usd Thousand); Figure 27 North America Sarcopenia Treatment Market: By Route Of Administration, Cagr (2023-2030); Figure 28 North America Sarcopenia Treatment Market: By Route Of Administration, Lifeline Curve; Figure 29 North America Sarcopenia Treatment Market: By Gender, 2022; Figure 30 North America Sarcopenia Treatment Market: By Gender, 2023-2030 (Usd Thousand); Figure 31 North America Sarcopenia Treatment Market: By Gender, Cagr (2023-2030); Figure 32 North America Sarcopenia Treatment Market: By Gender, Lifeline Curve; Figure 33 North America Sarcopenia Treatment Market: By End User, 2022; Figure 34 North America Sarcopenia Treatment Market: By End User, 2023-2030 (Usd Thousand); Figure 35 North America Sarcopenia Treatment Market: By End User, Cagr (2023-2030); Figure 36 North America Sarcopenia Treatment Market: By End User, Lifeline Curve; Figure 37 North America Sarcopenia Treatment Market: By Distribution Channel, 2022; Figure 38 North America Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand); Figure 39 North America Sarcopenia Treatment Market: By Distribution Channel, Cagr (2023-2030); Figure 40 North America Sarcopenia Treatment Market: By Distribution Channel, Lifeline Curve; Figure 41 North America Sarcopenia Treatment Market: Snapshot (2022); Figure 42 North America Sarcopenia Treatment Market: Company Share 2022 (%)